Cranial Technologies Introduces Infant Head Reshaping Treatment in China
SHANGHAI, November 7, 2025 — Cranial Technologies, a leading US medical device company specializing in infant head shape correction, has officially launched its DOC Band® treatment in China during the China International Import Expo (CIIE) held from November 5 to 10, 2025.
With more than 400,000 infants already treated in the United States and Europe, this milestone represents the company’s first step into the Chinese market and a significant expansion of its global footprint.
“We are truly honored to participate in CIIE for the first time — it is one of the world’s most influential platforms for global trade and innovation,”
said Debbie James, Chief Executive Officer of Cranial Technologies.
“CIIE provides an opportunity to establish meaningful partnerships that can help bring world-class infant care solutions to more Chinese families. Our mission aligns closely with the objectives of Healthy China 2030, making this an ideal time to begin a deeper dialogue with this important market.”
The company’s introduction to China corresponds with growing recognition of plagiocephaly, or flat head syndrome, among newborns. Studies show that roughly 25 percent of infants may need clinical intervention, a rate consistent with global figures.
Author’s Summary
Cranial Technologies expanded into China by launching the DOC Band® at CIIE 2025, marking a pivotal move to advance infant cranial health and support the Healthy China 2030 initiative.